A texaphyrin–oxaliplatin conjugate that overcomes both pharmacologic and molecular mechanisms of cisplatin resistance in cancer cells

Texaphyrins: Tumor Localizing Redox Active Expanded Porphyrins

(2012) Jonathan F. Arambula et al.   Anti-Cancer Agents in Medicinal Chemistry

Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53

(2011) Michelle Martinez-Rivera et al.   BIOCHEMICAL PHARMACOLOGY

Overcoming biochemical pharmacologic mechanisms of platinum resistance with a texaphyrin–platinum conjugate

(2011) Jonathan F. Arambula et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

The impact of S- and G2-checkpoint response on the fidelity of G1-arrest by cisplatin and its comparison to a non-cross-resistant platinum(IV) analog

(2011) Guangan He et al.   GYNECOLOGIC ONCOLOGY

Gadolinium texaphyrin (Gd-Tex)-malonato-platinum conjugates: Synthesis and comparison with carboplatin in normal and Pt-resistant cell lines

(2009) Jonathan F. Arambula et al.   DALTON TRANSACTIONS

Polyvalent Oligonucleotide Gold Nanoparticle Conjugates as Delivery Vehicles for Platinum(IV) Warheads

(2009) Shanta Dhar et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Conjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor Vasculature

(2007) Sumitra Mukhopadhyay et al.   BIOCONJUGATE CHEMISTRY